However, LRIG1 may be a novel T cell costimulatory receptor that is required for optimal anti-tumor T cell activation (the related information can be seen on the following webpage - https://app.dimensions.ai/details/grant/grant.6663751). The gene discussed is LRIG1; the disease is neoplasm.